Skip to main content
. 2014 Dec 22;2014:120317. doi: 10.1155/2014/120317

Table 7.

Comparison of the distribution of polymorphic variants of tested genes between ESRD patients treated with hemodialysis due to type 2 DM nephropathy grouped by diagnosis of CAD.

Parameter Type 2 DM nephropathy with CAD (frequency) Type 2 DM nephropathy without CAD (frequency) Odds ratio (95% CI) Two-tailed P P trend
IL18 rs360719 n = 124 n = 109

TT 68 (0.55) 53 (0.49) Referent 0.269
CT 51 (0.41) 49 (0.45) 1.128 (0.725–1.754) 0.653
CC 5 (0.04) 7 (0.06) 0.628 (0.194–2.036) 0.557
CT + CC 56 (0.45) 56 (0.51) 0.879 (0.560–1.380) 0.645
MAF 61 (0.25) 63 (0.29) 0.803 (0.532–1.211) 0.345

IL12A rs568408 n = 117 n = 102

GG 83 (0.71) 77 (0.63) Referent 0.361
AG 28 (0.24) 22 (0.22) 1.181 (0.623–2.236) 0.630
AA 6 (0.05) 3 (0.03) 1.855 (0.448–7.678) 0.502
AG + AA 34 (0.29) 25 (0.25) 1.262 (0.691–2.304) 0.542
MAF 40 (0.17) 28 (0.14) 1.311 (0.776–2.214) 0.378

IL12B rs3212227 n = 124 n = 109

AA 78 (0.63) 69 (0.63) Referent 0.906
AC 43 (0.35) 36 (0.33) 1.057 (0.611–1.829) 0.889
CC 3 (0.02) 4 (0.04) 0.664 (0.143–3.069) 0.708
AC + CC 46 (0.37) 40 (0.37) 1.017 (0.597–1.734) 1.000
MAF 49 (0.20) 44 (0.20) 0.974 (0.618–1.535) 0.909

IL4R rs1805015 n = 144 n = 127

TT 95 (0.66) 86 (0.68) Referent 0.947
CT 42 (0.29) 32 (0.25) 1.188 (0.689–2.048) 0.581
CC 7 (0.05) 9 (0.07) 0.704 (0.251–1.972) 0.605
CT + CC 49 (0.34) 41 (0.32) 1.082 (0.652–1.797) 0.797
MAF 56 (0.19) 50 (0.20) 0.985 (0.644–1.504) 0.944

IL13 rs20541 n = 144 n = 127

CC 80 (0.56) 71 (0.56) Referent 0.867
CT 55 (0.38) 46 (0.36) 1.061 (0.640–1.759) 0.898
TT 9 (0.06) 10 (0.08) 0.799 (0.307–2.077) 0.808
CT + TT 64 (0.44) 56 (0.44) 1.014 (0.627–1.640) 1.000
MAF 73 (0.25) 92 (0.26) 0.967 (0.657–1.423) 0.944

IL28B rs8099917 n = 163 n = 145

TT 105 (0.64) 97 (0.67) Referent 0.752
GT 52 (0.32) 42 (0.29) 1.144 (0.700–1.870) 0.618
GG 6 (0.04) 6 (0.04) 0.924 (0.288–2.961) 1.000
GT + GG 58 (0.36) 48 (0.33) 1.116 (0.697–1.189) 0.719
MAF 64 (0.20) 54 (0.19) 1.068 (0.714–1.597) 0.829

IL28B rs12979860 n = 163 n = 142

CC 69 (0.42) 66 (0.46) Referent 0.352
CT 73 (0.45) 62 (0.44) 1.126 (0.698–1.816) 0.715
TT 21 (0.13) 14 (0.10) 1.435 (0.674–3.055) 0.448
CT + TT 94 (0.58) 76 (0.54) 1.183 (0.752–1.861) 0.490
MAF 115 (0.35) 90 (0.32) 1.175 (0.838–1.647) 0.396

GC rs2298849 n = 172 n = 158a

TT 99 (0.58) 106 (0.67) Referent 0.173
CT 60 (0.35) 40 (0.25) 1.606 (0.989–2.608) 0.067
CC 13 (0.07) 12 (0.08) 1.160 (0.505–2.663) 0.833
CT + CC 73 (0.42) 52 (0.33) 1.503 (0.959–2.355) 0.088
MAF 166 (0.25) 64 (0.20) 1.313 (0.909–1.895) 0.174

GC rs7041 n = 161 n = 151

GG 57 (0.35) 46 (0.30) Referent 0.844
GT 69 (0.43) 82 (0.54) 1.327 (0.825–2.134) 0.277
TT 35 (0.22) 23 (0.15) 1.629 (0.900–2.949) 0.136
GT + TT 104 (0.65) 105 (0.70) 1.061 (0.721–1.559) 0.769
MAF 139 (0.43) 128 (0.42) 1.025 (0.746–1.409) 0.943

GC rs1155563 n = 172 n = 157

TT 82 (0.48) 79 (0.50) Referent 0.645
CT 70 (0.41) 61 (0.39) 1.106 (0.697–1.755) 0.724
CC 20 (0.12) 17 (0.11) 1.133 (0.554–2.321) 0.856
CT + CC 90 (0.52) 78 (0.50) 1.112 (0.721–1.714) 0.660
MAF 110 (0.32) 95 (0.30) 1.084 (0.779–1.508) 0.695

VDR rs2228570 n = 162 n = 152

CC 43 (0.27) 44 (0.29) Referent 0.316
CT 93 (0.57) 68 (0.45) 1.400 (0.829–2.363) 0.230
TT 26 (0.16) 40 (0.26) 0.665 (0.348–1.272) 0.252
CT + TT 119 (0.73) 108 (0.71) 1.128 (0.688–1.849) 0.705
MAF 145 (0.45) 148 (0.49) 0.854 (0.624–1.169) 0.365

VDR rs1544410 n = 170 n = 155

GG 65 (0.38) 61 (0.39) Referent 0.772
AG 79 (0.46) 72 (0.46) 1.030 (0.641–1.653) 0.905
AA 26 (0.15) 22 (0.14) 1.109 (0.569–2.160) 0.865
AG + AA 105 (0.62) 94 (0.61) 1.048 (0.671–1.639) 0.909
MAF 131 (0.39) 116 (0.37) 1.048 (0.763–1.440) 0.833

RXRA rs10776909 n = 172 n = 158

CC 112 (0.65) 104 (0.66) Referent 0.621
CT 48 (0.28) 47 (0.30) 0.948 (0.585–1.537) 0.902
TT 12 (0.07) 7 (0.04) 1.592 (0.604–4.198) 0.473
CT + TT 60 (0.35) 54 (0.34) 1.032 (0.655–1.625) 0.908
MAF 72 (0.21) 61 (0.19) 1.107 (0.756–1.621) 0.672

RXRA rs10881578 n = 173 n = 158

AA 89 (0.51) 92 (0.58) Referent 0.192
AG 65 (0.38) 53 (0.34) 1.268 (0.796–2.019) 0.345
GG 19 (0.11) 13 (0.08) 1.511 (0.704–3.241) 0.340
AG + GG 84 (0.49) 66 (0.42) 1.316 (0.852–2.032) 0.226
MAF 103 (0.30) 79 (0.25) 1.272 (0.902–1.793) 0.199

RXRA rs749759 n = 169 n = 153

GG 100 (0.59) 89 (0.58) Referent 0.812
AG 59 (0.35) 54 (0.35) 0.972 (0.610–1.551) 1.000
AA 10 (0.06) 10 (0.07) 0.890 (0.354–2.238) 0.818
AG + AA 69 (0.41) 64 (0.42) 0.960 (0.615–1.496) 0.910
MAF 79 (0.23) 74 (0.24) 0.956 (0.665–1.375) 0.882

CAD: coronary artery disease, ESRD: end-stage renal disease, DM: diabetes mellitus, and MAF: minor allele frequency.

aNot consistent with Hardy-Weinberg equilibrium.